(Q40348331)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304638%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Selective expansion and engraftment of human CD16+ NK cells in NOD/SCID mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304638%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304638%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Hideki Harada

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304638%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Takaaki Ito

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304638%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Seiji Okada

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304638%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304638%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304638%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304638%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304638%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

3599-3609

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304638%20AND%20SRC:MED&resulttype=core&format=json

NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Human natural killer cells: their origin, receptors and function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Natural killer cells and viral infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

The biology of human natural killer-cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Cancer immunotherapy with natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Natural killer cells and cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Immune inhibitory receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

On guard--activating NK cell receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Human natural killer cell receptors and co-receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Different checkpoints in human NK-cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/γcnull mice model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

A GFP-transfected HFWT cell line, GHINK-1, as a novel target for non-RI activated natural killer cytotoxicity assay

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

The Fc gamma receptor of natural killer cells is a phospholipid-linked membrane protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Determination of lymphocyte division by flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

A novel enhanced green fluorescent protein (EGFP)-K562 flow cytometric method for measuring natural killer (NK) cell cytotoxic activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021

Interleukin 15: biology and relevance to human disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535125

7 January 2021